Carol Giltner Gallagher

ATRA

Carol Giltner Gallagher serves as Director at Atara Biotherapeutics, Inc. (ATRA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$68.2K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$68.2K

Companies Traded

ATRA

Active Period

Nov 2023

1 total trades

Most Recent

Buy ATRA

Nov 13, 2023 · $68.2K

Carol Giltner Gallagher's Insider Trading at Atara Biotherapeutics, Inc. (ATRA)

Buys

1 · $68.2K

Sells

0 · $0.00

Total Shares Bought

270,000

Total Shares Sold

ATRA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 13, 2023	Buy	270,000	$0.25	$68.2K	0

Related Insiders

Panacea Innovation Ltd

10 percent owner

ATRASell · Jan 14, 2026

Yanina Grant-Huerta

Chief Accounting Officer

ATRASell · Nov 17, 2025

AnhCo Nguyen

President and CEO

ATRASell · Nov 17, 2025

Explore More Insider Trading Data

ATRA Insider Trading Activity

View all insider trades at Atara Biotherapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity